Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Stereotactic Radiosurgery With Cyberknife In Patients With Brain Melanoma Metastases In The Era Of New Drugs

NCT07691255 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07691255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07691255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Stereotactic Radiosurgery With Cyberknife In Patients With Brain Melanoma Metastases In The Era Of New Drugs
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
August 25, 2026
Completion date
January 1, 2030
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin cancer)